PMID: 8939642Dec 1, 1996Paper

Agents that target telomerase and telomeres

Current Opinion in Biotechnology
E RaymondD D Von Hoff

Abstract

Telomeres are guanine-rich regions that are located at the ends of chromosomes and are essential for preventing aberrant recombination and protecting against exonucleolytic DNA degradation. Telomeres are maintained by telomerase, an RNA-dependent DNA polymerase. Because telomerase is known to be expressed in tumor cells, which concurrently have short telomeres, and not in most somatic cells, which usually have long telomeres, telomerase and telomere structures have been recently proposed as attractive targets for the discovery of new anticancer agents. The most exciting current strategies are aimed at specifically designing new drugs that target telomerase or telomeres and new models have been formulated to study the biological effects of inhibitors of telomerase and telomeres both in vitro and in vivo.

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R C AllsoppC B Harley
Jul 1, 1992·Experimental Gerontology·C B HarleyR C Allsopp
Jun 1, 1992·Trends in Genetics : TIG·W E Wright, J W Shay
Jun 20, 1992·Journal of Molecular Biology·M Z LevyC B Harley
Apr 18, 1991·Nature·E H Blackburn
Oct 18, 1991·Cell·D P Romero, E H Blackburn
Apr 25, 1991·Nature·A M ZahlerD M Prescott
Aug 30, 1990·Nature·N D HastieR C Allshire
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J MeyneR K Moyzis
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R K MoyzisJ R Wu
Oct 1, 1995·Japanese Journal of Cancer Research : Gann·H OhmuraM Oshimura
Dec 8, 1995·Science·L ChongT de Lange
Sep 1, 1995·Science·J FengJ Yu
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·D BroccoliT de Lange
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·C B HarleyC W Greider
Apr 1, 1995·Current Opinion in Genetics & Development·C B Harley, B Villeponteau
Jul 21, 1995·Science·M Cohn, E H Blackburn
Sep 15, 1995·The Journal of Biological Chemistry·N F Lue, J C Wang
Jun 21, 1995·Journal of the National Cancer Institute·G B Morin
Jun 21, 1995·Journal of the National Cancer Institute·K HiyamaJ W Shay
Feb 1, 1995·Nature Genetics·D Kipling
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·P A KrukV A Bohr
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·J P HanishT de Lange
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·T de Lange
Feb 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K R ProwseC W Greider
Feb 1, 1996·Nature Medicine·N Axelrod
Jun 19, 1996·Journal of the National Cancer Institute·K Mokbel, M Ghilchik
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·X ZhuR Narayanan
Jun 1, 1996·Current Opinion in Cell Biology·K Collins
Jan 1, 1996·Important Advances in Oncology·C B Harley, N W Kim
Dec 1, 1996·Current Opinion in Biotechnology·E RaymondD D Von Hoff
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Sylvain Huard, Chantal Autexier
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yidong FanDawei Xu

❮ Previous
Next ❯

Citations

Dec 16, 1997·Obstetrics and Gynecology·G H Eltabbakh
Mar 10, 1999·Leukemia Research·H D Preisler
Mar 31, 2000·Pharmacology & Therapeutics·S NeidleM A Read
Oct 1, 1996·Mutation Research·C M Counter
Mar 8, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G XinarianosJ K Field
May 22, 2003·Cancer Letters·Eiso Hiyama, Keiko Hiyama
Dec 1, 1996·Current Opinion in Biotechnology·E RaymondD D Von Hoff
Jan 16, 1999·Current Opinion in Biotechnology·S A Courtneidge, G D Plowman
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J W Shay, S Bacchetti
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T M Bryan, R R Reddel
Mar 28, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C P ReynoldsR C Seeger
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J MurakamiK Ohama
May 9, 2000·Critical Reviews in Oncology/hematology·F LavelleP Mailliet
Feb 14, 2002·Critical Reviews in Oncology/hematology·Meaghan P GrangerJerry W Shay
Dec 25, 2003·Urologic Oncology·Tarek M MekhailRonald Bukowski
Jan 29, 2000·Mutation Research·C Cerni
Feb 13, 2009·Journal of the American Chemical Society·Yan XuMakoto Komiyama
Mar 3, 2010·Journal of the American Chemical Society·Ken-ichi ShinoharaHiroshi Sugiyama
Aug 1, 1998·Nucleic Acids Research·H ArthanariP H Bolton
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J M GuoS Zhang
Jul 13, 2002·Expert Review of Anticancer Therapy·L Austin Doyle, W Edward Highsmith
Jul 5, 2005·Expert Opinion on Investigational Drugs·S SharmaD D Von Hoff
Jan 5, 2001·Expert Opinion on Investigational Drugs·P J Perry, T C Jenkins
Feb 7, 2001·Cancer Investigation·A J Davis, L L Siu
Feb 22, 2002·Cancer Investigation·Marco N HelderG J van der Zee
Jul 20, 2005·Biochemical Pharmacology·Miroslav HájekEva Tloust'ová
Jan 24, 2003·Expert Opinion on Therapeutic Targets·Terace M Fletcher
Apr 18, 2001·Chemistry & Biology·H Arthanari, P H Bolton
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Marco N. HelderAte G. J. van der Zee
Nov 25, 1998·Cancer·S SakuraiM Koike
Feb 16, 2019·Toxicological Research·Mohamed Mohammed HashemMona M E Eleiwa
Nov 21, 1998·Journal of Medicinal Chemistry·P J PerryS Neidle
Jul 20, 1999·Journal of Medicinal Chemistry·P J PerryS Neidle
Sep 13, 2001·Journal of the American Chemical Society·H HanL H Hurley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.